News Focus
News Focus
Followers 59
Posts 7593
Boards Moderated 0
Alias Born 10/20/2014

Re: Number sleven post# 438205

Thursday, 08/21/2025 10:50:50 PM

Thursday, August 21, 2025 10:50:50 PM

Post# of 447907
Obviously Alex Denner did not expect the share price of AMRN
to fall to the levels it did, so whatever he may have had in mind
did not work out, at least as initially planned. Also, it took a
long time for Denner to figure out that having AMRN build a
sales force for Europe was impractical. I certainly hope that
SDL is correct in his supposition that NVS will acquire AMRN.
At some point I hope we get some details on the new formulation
and exactly what AMRN plans to do with it. Will they use it as
a platform drug? Will they attempt to get it approved for new
indications? Will they use it as bait for a BP BO? Before I get
excited about any of this I hope too see the share price surge
much higher.
I
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News